The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and ¹⁸F-fluorodeoxyglucose positron emission tomography

Abstract

Before and after neoadjuvant chemotherapy for breast cancer, the ΔD(max) of MRI correlated moderately with the ΔSUV on PET. For prediction of the pCR, MRI proved to be a more specific modality than PET.